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Abstract
Background: To generate specific transcript profiles, one must isolate homogenous cell populations using
techniques that often yield small amounts of RNA, requiring researchers to employ RNA amplification methods.
The data generated by using these methods must be extensively evaluated to determine any technique dependent
distortion of the expression profiles.
Results:  High-density oligonucleotide microarrays were used to perform experiments for comparing data
generated by using two protocols, an in vitro transcription (IVT) protocol that requires 5 µg of total RNA and a
double in vitro transcription (dIVT) protocol that requires 200 ng of total RNA for target preparation from RNA
samples extracted from a normal and a cancer cell line. In both cell lines, about 10% more genes were detected
with IVT than with dIVT. Genes were filtered to exclude those that were undetected on all arrays. Hierarchical
clustering using the 9,482 genes that passed the filter showed that the variation attributable to biological
differences between samples was greater than that introduced by differences in the protocols. We analyzed the
behavior of these genes separately for each protocol by using a statistical model to estimate the posterior
probability of various levels of fold change. At each level, more differentially expressed genes were detected with
IVT than with dIVT. When we checked for genes that had a posterior probability greater than 99% of fold change
greater than 2, in data generated by IVT but not dIVT, more than 60% of these genes had posterior probabilities
greater than 90% in data generated by dIVT. Both protocols identified the same functional gene categories to be
differentially expressed. Differential expression of selected genes was confirmed using quantitative real-time PCR.
Conclusion: Using nanogram quantities on total RNA, the usage of dIVT protocol identified differentially
expressed genes and functional categories consistent with those detected by the IVT protocol. There was a loss
in sensitivity of about 10% when detecting differentially expressed genes using the dIVT protocol. However, the
lower amount of RNA required for this protocol, as compared to the IVT protocol, renders this methodology a
highly desirable one for biological systems where sample amounts are limiting.
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Background
High throughput DNA microarray technology has proved
to be a powerful approach for gene expression profiling in
various cellular systems and has played a significant role
in the molecular classification of cancer [1-5]. To generate
a meaningful transcript profiling pattern specific to a
desired cell type, it is essential to isolate a homogenous
cell population using techniques such as cell sorting or
laser capture microdissection [6]. However, such tech-
niques yield low amounts of RNA, usually insufficient to
perform DNA microarray experiments. In such cases, it is
often necessary to employ RNA amplification methods to
generate the microgram quantities of RNA required to per-
form these experiments. The use of RNA amplification
methods warrants a thorough analysis and understanding
of the variations introduced due to the methodology
employed. It is vital to be able to distinguish between the
real effects of the biological system being analyzed and
changes introduced due to a difference in the methods
used to generate the data.
Here we present a comparative analysis of the data gener-
ated using two different target preparation techniques for
hybridization to high-density oligonucleotide microar-
rays (U95Av2 GeneChips, Affymetrix, Santa Clara, CA;
[7]). We have performed transcription-profiling experi-
ments with samples extracted from normal human trache-
obronchial epithelial cells (NHTBE; Clonetics, San Diego,
CA) and human pulmonary mucoepidermoid carcinoma
cells (NCI-H292; American Type Culture Collection,
Manassas, VA). These profiling experiments used U95Av2
GeneChips (Affymetrix, Santa Clara, CA) and two differ-
ent methods for target preparation, namely, a standard
protocol (involving in vitro transcription, IVT; [7,8]) and
an amplification protocol (involving double in vitro tran-
scription, dIVT; [7,9]). In the IVT protocol, 5–40 µg of
total RNA is reverse-transcribed to generate cDNA using
an oligo-dT primer containing the T7 promoter sequence.
The cDNA is converted into double stranded DNA using
random hexamers and transcribed in vitro in the presence
of biotinylated ribonucleotides to generate biotin-labeled
complementary RNA (cRNA). The cRNA is fragmented
and hybridized to the arrays. The dIVT protocol, which
requires only 50–250 ng of total RNA, is a modification of
the IVT protocol where unlabeled cRNA is first synthe-
sized followed by a second round of reverse transcription
to generate cDNA and in vitro transcription to synthesize
biotin-labeled cRNA.
Our results showed that the variation attributable to bio-
logical differences between samples was greater than that
introduced by differences in the protocols used for target
preparation. To identify differentially expressed genes
between the two cell lines, we compared the posterior
probability of fold change exceeding various thresholds in
either protocol. When we checked for genes that had a
posterior probability greater than 99% of fold change
greater than 2, in data generated by IVT but not dIVT,
more than 60% of these genes had posterior probabilities
greater than 90% in data generated by dIVT. Moreover,
both protocols identified many genes in the same func-
tional categories to be differentially expressed. Although
the dIVT protocol is less sensitive than the IVT (a 10% loss
of detection in the number of genes whose expression lev-
els could be measured), the requirement of much lesser
amount of sample required for dIVT protocol (20–100
times less than IVT protocol), makes it a highly desirable
methodology for target preparation, when sample
amounts are limiting.
Results and Discussion
In order to be able to perform DNA microarray experi-
ments using limited amounts of starting samples, several
studies in the recent years have used amplification meth-
ods to generate sufficient RNA for these experiments. In
these cases, it is vital to understand the relative effects of
amplification methods on the results generated by these
studies. The goal of this study is to perform a comparative
analysis of the data generated using two different target
preparation techniques for hybridization to high-density
oligonucleotide microarrays (U95Av2 GeneChips,
Affymetrix, Santa Clara, CA; [7]), an in vitro transcription
(IVT; [7,8]) protocol that requires 5 µg of total RNA and a
double in vitro transcription amplification protocol (dIVT;
[7,9]). Total RNA samples extracted from 2 cell lines, nor-
mal human tracheobronchial epithelial cells (NHTBE;
Clonetics, San Diego, CA) and human pulmonary
mucoepidermoid carcinoma cells (NCI-H292; American
Type Culture Collection, Manassas, VA) were used for tar-
get preparation using IVT and dIVT protocols. The data set
generated, consisted of 2 replicates per cell line per proto-
col used, resulting in a total of eight experiments that were
used to investigate both cell type-based (normal and can-
cer) and protocol-based effect (IVT and dIVT) on the final
results.
Quality Control
As an initial quality control measure to check for varia-
tions introduced by differences in target preparation,
labeling, hybridization, and handling of individual sam-
ples, we compared the data reports for all the arrays as
generated by MAS 5.0 [10]. The background levels and the
range of percentage of probe sets called present (25–48%)
were within acceptable levels as described previously [10].
All the exogenously added prokaryotic hybridization con-
trols showed signal intensities significantly above thresh-
old limits [10] in all reports. Similar results were obtained
for housekeeping genes such as GAPDH and β-actin, high-
lighting the efficiency and accuracy of target preparation
and hybridization.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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Further quality control was performed at 4 levels (1) auto-
mated grid alignment of the probe cells, (2) spatial varia-
tion of probe cells, (3) probe outliers, and (4)
distributions of the detection p-values. Automated grid
alignment and spatial variation of probe cells were exam-
ined at the .CEL file level using MATLAB scripts [11].
Briefly, to assess grid alignment, we checked the alternat-
ing pattern of positive and negative control cells in the
borders of each GeneChip. The borders of the chips con-
sist of alternate probe cells containing oligonucleotide B2
(a DNA sequence complementary to this oligonucleotide
is included in the hybridization cocktail) and oligonucle-
otide B1 that serve as positive and negative controls
respectively (Affymetrix, Santa Clara, CA). The intensities
for positive controls (blue) and negative controls (red)
were plotted as a function of probe cell column position
to determine the quality of grid alignment for each chip
(Figure 2). Intersection of the spectra for positive (blue)
and negative (red) control intensities would signify an
alignment drift out of phase. Spatial variation in the probe
cells was assessed by plotting the coefficient of variation
of pixel-level intensities within each probe cell on a chip
by position (Figure 3). This analysis is useful in detecting
any spatial artifacts on the microarray. The overall quality
of the arrays was assessed with dChip [12] to compute the
percentage of array outliers and single outliers. For each
array, array outliers measure the percent of probe sets with
expression patterns that are inconsistent from the rest of
the arrays. Single outliers are analogous for single probes,
measuring the percent of probe outliers on each array
(Table 1). In general, dChip flags an array when either sin-
gle or array outlier percentages exceed 5% and recom-
mends removal of arrays from further analysis when any
of these values is 15% or more. None of the chips were
flagged based on these criteria. Finally, we looked at the
percentage of probe sets on each array with detection p-
values less than 0.01 or 0.05 (Table 1). Detection p-values
are a measure of how likely a transcript was expressed at a
level to be called present on the array. As a general rule,
chips with less than 10% of the probe sets detected with p
< 0.01 are excluded from further analysis. This rule was
derived from empirical experience. All GeneChips in this
study passed all four quality control checks.
Fragmentation of cRNA Figure 1
Fragmentation of cRNA Aliquots of 2 cRNA samples were analyzed by agarose gel electrophoresis, before (lanes 1 and 2) 
and after (lanes 3 and 4) fragmentation.
1     2 3 4       5
cRNA before     cRNA after     Marker
fragmentation      fragmentationBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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Comparison of the ability to detect genes using IVT and 
dIVT protocols
The ability of the two protocols to detect expressed genes
was examined using detection p-values. Because replicate
chips were available, we had two measures of detection
for each probe set in each group. We took as the detection
p-value the maximum for each probe set over replicates as
a conservative estimate of detection. The empirical distri-
bution functions, which measure for any value x the per-
centage of values in the empirical sample less than or
equal to x, of detection p-values were plotted by protocol
and sample type (Figure 4). Regardless of protocol, more
probe sets were detected in cancer cells than in normal
cells (compare figure 4C with A). Almost all probe sets
detected with the dIVT protocol were also detected (at the
same p-value cutoff) with the IVT protocol (Figure 4B and
4D). In both cell lines, significantly more probe sets were
detected (at a given cutoff of the detection p-value) using
the IVT protocol than were detected using the dIVT proto-
col (Figure 4A and 4C). For example, at a detection cutoff
of p < 0.01 in the NCI-H292 cancer cell line, approxi-
mately 11% of the genes detected using IVT were not
detected using dIVT (Figure 4C). At the same cutoff in the
NHTBE cells, 8% of genes detected using IVT were not
detected using dIVT (Figure 4A). At a detection cutoff of p
< 0.05, the differences in detection rates were 12% and
10%, respectively. Additional detection in both normal
and cancer cell lines with dIVT was less than 2% at these
levels.
Grid alignment on microarrays Figure 2
Grid alignment on microarrays. Plot of the intensity of positive controls (blue) and negative controls (red) from left to 
right across the top of the image, confirming that the scanner and quantification software were correctly aligned with the fea-
tures on the microarray. The x-axis represents the column index from chip left top to right top corner. The y-axis represents 
the 75th percentile of signal intensity of pixels in each probe cell.
Column Index of Probe Cells (left top to right top)
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The decrease in the number of genes detected by dIVT is
likely due to truncation of the 5' end of the RNA during
amplification, as reported by McClintick and colleagues
[15]. Luzzi and colleagues [8] found a similar decrease
Spatial variation on microarrays Figure 3
Spatial variation on microarrays Coefficient of variation of pixel-level intensities within each probe cell on a U95Av2 chip 
are plotted by probe cell position on the chip, confirming that there are no spatial artifacts on the microarray.
Table 1: Quality metrics for 8 GeneChips using dChip (percentage of array outliers or single outliers) and MAS (percentage of probe 
sets with significant detection p-values)
Experiment Array outliers (%) Single outliers (%) Detection P < 0.01 (%) Detection P < 0.05 (%)
1. IVT, NHTBE 0.02 0.04 21 31
2. IVT, NHTBE 0.06 0.16 24 34
3. IVT, NCI-H292 0.05 0.04 35 45
4. IVT, NCI-H292 0.23 0.09 36 47
5. dIVT, NHTBE 0.02 0.06 22 32
6. dIVT, NHTBE 0.40 0.20 13 20
7. dIVT, NCI-H292 0.03 0.19 25 34
8. dIVT, NCI-H292 0.04 0.10 26 36
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(11–16%) in the number of genes called present when
using an amplification protocol for target preparation for
hybridization to HuGeneFL microarray (Affymetrix, Santa
Clara, CA). They also found that the overall hybridization
signal, as measured by the scaling factor used for normal-
ization in MAS 4.0, was approximately two-fold lower
when using amplification.
By contrast, several studies have reported an increase in
the number of detectable genes when combining amplifi-
cation techniques with microarrays that use spotted
cDNAs or long oligonucleotides on glass slides [16-19].
Hu and colleagues [16] suggested that the increase was
due primarily to improvements in the signal intensity of
low abundance genes, raising them above the noise level
on the arrays. The difference in findings on the two differ-
ent microarray platforms is probably related both to bio-
chemical differences in the probe design and to
differences in bioinformatical processing algorithms.
According to a recently published thermodynamic model
for estimating gene expression levels on oligonucleotide
microarrays [20], it is conceivable that focusing on probes
closer to the 3' end would find similar increases in the
detection of low abundance transcripts.
Empirical Distributions of the Detection p-values Figure 4
Empirical Distributions of the Detection p-values Detection p-values (x-axis) are plotted against the empirical cumula-
tive probability (y-axis) of values less than those on the corresponding curve. Plots shown in (A) and (B) represent data from 
normal cell line and those in (C) and (D) correspond to cancer cell line. The gap between curves in the plots shown in (A) and 
(C) corresponds to about 10% of the genes that were detected using the IVT but not the dIVT protocol. The near coincidence 
of graphs in (B) and (D) shows that virtually all genes detected using the dIVT protocol are also detected using the IVT 
protocol.
(A) (B)
(C) (D)BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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Determination of overall variation in samples by 
hierarchical clustering
Next, we used hierarchical clustering to explore the rela-
tive overall variation observed due to differences in sam-
ple source (cell lines) and protocol (IVT and dIVT) used
for target preparation. The hierarchical clustering algo-
rithm is agglomerative in that it joins samples based on a
measure of multivariate distance, and once joined these
samples are not free to cluster independently again. Pair-
wise joins in samples are represented as combined
branches of a tree in a Dendrogram Plot (Figure 5). Since
the results can be sensitive to the distance measure speci-
fied, both Euclidean and Pearson Correlation were used to
determine if samples clustered together predominantly by
protocol or biology. The probe sets were filtered based on
detection p-values. For a probe set to be included in this
analysis, the detection p-value had to be less than 0.3 on
at least one chip. This choice was liberal enough to
include most probe sets and to exclude the noisiest probe
sets with the weakest signal. Of the 12,625 probe sets on
the U95Av2 microarray, 9,482 passed this filter. We clus-
tered samples by Euclidean distance between the logarith-
mic expression values of these 9,482 genes (Figure 5A).
The major split in the clusters reflects the biological differ-
ence between cancer and normal samples, and the differ-
ence in protocols is a secondary effect. Within each group
of samples, reproducibility (as measured by Euclidean
distance between samples) was better with the IVT proto-
col than the dIVT protocol. Clustering based on the Pear-
son correlation between logarithmic expression values led
to similar results (Figure 5B). These findings are consistent
Hierarchical Clustering of samples Figure 5
Hierarchical Clustering of samples Dendrograms of the samples based on the logarithmic expression values of 9,482 
genes, using complete linkage and either (A) Euclidean distance or (B) Pearson correlation. Samples clustered by biological ori-
gin regardless of the target preparation protocol used. Suffix labels A and B denote replicates.
(A) (B)BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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with those from previous reports that used amplification
protocols for target preparation for hybridization to
microarrays [21,22].
The biologic differences between the two human cell
lines, normal tracheobronchial epithelial cells and pul-
monary mucoepidermoid carcinoma cells, used in this
study were expected to be quite significant. Hierarchical
clustering showed that the variation between cell lines
exceeded variation between protocols. Similar analysis
performed using two more closely related samples may
show larger relative variation by protocol.
Comparison of differentially expressed genes detected by 
IVT and dIVT protocols
The filtered dataset consisting of 9,482 genes (generated
above) was used for comparing differentially expressed
genes detected by IVT and dIVT protocols. Each of the
9,482 probe sets was modeled separately for each hybrid-
ization protocol using a linear model (see equations 1 and
2 below) to account for overall expression, cell line, and
other variation on the logarithmic scale.
IVT Protocol (5 µg): log2(Ygi1k) = µg1 + τgi1 + εgi1k εgi1k ~ N(0,
σ2
1)   (1)
DIVT Protocol (0.2 µg): log2(Ygi2k) = µg2 + τgi2 + εgi2k εgi2k ~
N(0, σ2
2)   (2)
g = 1, ..., 12625 probe sets, i = 1, 2 Cancer/Normal
k = 1, 2 Replicate Chips
The first term in each model, µ, accounted for the overall
log mean expression. The second term, τ, accounted for
differences between the normal cell line (NHTBE) and the
cancer cell line (NCI-H292) on the log scale and repre-
sented fold change (FC) on the original scale. The final
term,  ε, accounted for unexplained variation and was
modeled with a normal distribution on the log base 2
scale with mean 0 and variance σ2. Since no prior infor-
mation was available for these parameters, they were
assumed to be generated a priori from uninformative prior
distributions. The data were used to update our prior
knowledge to produce posterior distributions [13]. These
distributions were used to compute the posterior
probability
P(FC < 1/∆ ∪ FC > ∆ | Data)   (3)
that FC  by cell line exceeded some desired amount ∆.
Hence, for a given ∆, a high posterior probability in (3) is
strong posterior evidence that the expected FC lies outside
of the interval (1/∆,  ∆). We examined these posterior
probabilities for probe sets meeting the change criterion
in each protocol for FC > ∆ = 1.5, 2, 4, 8 and probability
cutoffs of 85%, 90%, 95% and 99% (Table 2). At each
level of desired FC and probability cutoff, more differen-
tially expressed probe sets were discovered with the IVT
protocol than the dIVT protocol (compare columns 3 and
4 in table 2). This finding is consistent with the results pre-
sented above (Figure 4).
Figure 6A displays a Venn diagram comparing protocol
performance for the criterion P(FC < 1/2 ∪ FC > 2) > 99%
Table 2: Number of differentially expressed genes detected by each protocol as a function of the minimum fold change and the posterior 
probability of exceeding it
Fold Change Posterior Probability IVT dIVT Both*
1.5 0.99 430 311 116
0.95 1411 1122 513
0.90 2206 1737 852
0.85 2799 2234 1144
2 0.99 222 150 59
0.95 694 542 256
0.90 1073 883 428
0.85 1375 1145 551
40 . 9 9 7 65 01 9
0.95 207 155 90
0.90 298 249 142
0.85 375 314 179
80 . 9 9 3 32 1 6
0.95 90 69 44
0.90 129 97 65
0.85 152 121 79
*number of genes observed to be differentially expressed by both protocolsBMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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with the detection criterion implemented. Using these cri-
teria 59 genes were found to be differentially expressed by
both protocols, 163 found in IVT alone, and 91 in dIVT
alone. The histograms in figures 6B and 6C shows that
nearly 60% of probe sets discovered with only one proto-
col still had posterior probabilities exceeding 90% in the
other. For FC = 8, about 31% of probe sets exceeded the
top 93rd rank in both protocols. Therefore we concluded
that although fewer probe sets were discovered in the dIVT
protocol, many were still detectable for differential expres-
sion at a lower threshold. This is a significant extension to
the previous report by McClintick and coworkers [15] that
relied on MAS probe set specific present/absent calls for
detection analysis. They observed that genes at lower lev-
els of detection were less reproducible in comparing treat-
ment groups. We considered a range of cutoffs for
detecting signal and change. We found that while repro-
ducibility varied, for those genes showing at least FC of 2
with 99% posterior probability in just one protocol,
approximately 60% were detectable in the other for a
slightly reduced posterior probability cutoff of 90% (Fig-
ure 6B and 6C).
Comparison of functional gene categories identified as 
differentially expressed by IVT and dIVT protocols
Since the two protocols did not identify identical sets of
differentially expressed genes, we investigated whether the
functional categories of the genes that were identified as
differentially expressed were consistent. Each differen-
tially expressed gene was annotated using functional
annotations downloaded from the dChip web site, http:/
/biosun1.harvard.edu/complab/dchip/info_file.htm. The
number of differentially expressed genes detected by dIVT
and IVT protocols in each functional category (with a pos-
terior probability of 0.99 of having a fold change at least
equal to 2) is shown in column 2 in tables 3 and 4, respec-
tively. These tables also show a count of a subset of these
genes that were identified as differentially expressed by
the alternate protocol for different cutoffs (>0.90, >0.95
and > 0.99; columns 3, 4 and 5 in tables 3 and 4) on the
posterior probability. In most functional categories, many
genes detected with a posterior probability of 0.99 of hav-
ing a fold change at least equal to 2 in one protocol were
discovered at the slightly lower threshold of 0.90 in the
other protocol (compare column 2 with column 3 in
tables 3 and 4). These data show that the results generated
by the two methods identify the same functional gene cat-
egories to be differentially expressed. Although the
number of genes identified to be differentially expressed
in each category by the two protocols may be different, the
usage of any of these protocols will identify the same func-
tional pathways to be affected when comparing the two
cell lines.
Confirmation by QRT-PCR
Among the genes that were identified as differentially
expressed by at least one protocol with a posterior proba-
bility of 0.99 of FC exceeding 2, 10 were selected for con-
firmation studies using QRT-PCR. Differences in
expression of these genes between the NHTBE and NCI-
H292 were estimated using the comparative CT method
[14], normalizing the values relative to the housekeeping
gene, GAPDH. Each gene was tested in duplicate reactions
in three independent experiments. Replicates were used to
compute 90% confidence intervals on the ∆∆CT scale,
which were then converted to confidence intervals on the
FC scale (Table 5). For each gene, array FC model esti-
mates are listed for IVT and dIVT protocols in columns 2
and 3, respectively. These are printed in bold by protocol
for those meeting the change criterion. Notice that these
show array FC estimates well exceeding 2 for their respec-
tive protocols. Four probesets were selected which met the
change criterion in both protocols (TNF, K6A, SFP and
IGFB), from the 59 in the set intersection in Figure 6A
(center), two in IVT alone (LOH and AXL) from the 163
in the exclusive IVT set (left), and four in dIVT alone
(DMP, GR, EGFR and NFKB), from the 91 in the exclusive
dIVT set (right). The following three columns list FC with
90% lower and upper bounds as modeled from the QRT-
PCR data. Down regulation is reported as 1/FC. Eight of
the 10 differentially expressed genes tested, as determined
by the microarray data using either protocol, produced
similar results with QRT-PCR. SFP was observed to be up
regulated by both array protocols and unchanged (QRT-
PCR Est. FC = 1/1.05) by QRT-PCR. QRT-PCR results for
EGFR showed down regulation while up on both array
protocols. These contradictory results may be due to the
presence of degenerate probe sets for these transcripts on
the arrays that may cross hybridize with other genes, lead-
ing to false results. In a recently published report, out of a
set of 66 genes identified as differentially expressed by
macroarray screening, only 40 genes could be validated by
QRT-PCR [23].
Conclusion
This study was performed to compare the relative effects
of using two different protocols for target preparation for
hybridization to high-density oligonucleotide arrays, on
the final results generated by these experiments. Samples
from two different human cell lines, a normal and a can-
cer cell line, were used for target preparation by the two
different methods and hybridized to U95Av2 GeneChips.
The conclusions derived from this study were that: (1) the
decrease in the number of genes detected with the dIVT
protocol was not substantial. For the 0.01 and 0.05 levels,
the loss in detection for amplification was 8% and 10%
respectively in the normal cell line. The loss was 11% and
12% in the cancer line (see Figure 4), (2) when comparing
differentially expressed genes that had a posterior proba-BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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Comparison of differentially expressed genes detected by IVT and dIVT protocols Figure 6
Comparison of differentially expressed genes detected by IVT and dIVT protocols (A) Venn diagram comparing 
genes with P(FC < 1/2 ∪ FC > 2) > 99% shows 59 genes overlapped between the data generated by the 2 protocols. (B) Histo-
gram of the posterior probability P(FC < 1/2 ∪ FC > 2) in dIVT experiments for the 163 genes only called different using the 
IVT protocol. (C) Histogram of the posterior probability P(FC < 1/2 ∪ FC > 2) in IVT experiments for the 91 genes only called 
different using the dIVT protocol. (A) and (B) show that more than 60% of the genes detected by only one protocol had poste-
rior probabilities exceeding 90% in the other.
(B)
(A) 
(C ) BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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bility greater than 99% of fold change greater than 2, in
data generated by IVT but not dIVT, more than 60% of
these genes had posterior probabilities greater than 90%
in data generated by dIVT. Thus, these genes may still have
been discovered using dIVT protocol at a lower threshold
based on a search, for instance that stressed functional
stratification rather than simple criteria inclusion, (3) the
two protocols showed reasonable agreement in the func-
tional categories identified to be differentially expressed
based on the gene lists generated by each protocol and (4)
hierarchical clustering showed that variation due to biol-
ogy of the samples was higher than that due to protocols
used for target preparation.
Methods
Cell Culture and RNA Extraction
NHTBE cells (strain 6178, Clonetics, San Diego, CA) were
seeded onto a 24 mm permeable membrane insert (1 ×
Table 3: Detection of differentially expressed genes by dIVT Protocol for different functional gene categories
Functional Category 
P(FC < 1/2 ∪ FC > 2)
Number of Genes 
Detected by dIVT with 
>.99
Number of Genes also Detected by IVT with
>.90 >.95 >.99
A p o p t o s i s  r e g u l a t o r 0000
Cell-cell signaling 10 8 7 4
Cell cycle 9410
C e l l  d e a t h 2222
Cell motility 5550
Cell proliferation 17 14 11 5
D e f e n s e  a n d  I m m u n i t y 6642
Extracelullar 16 13 12 5
H o m e o s t a s i s 1000
Nucleic acid binding 19 7 4 3
P a t h o g e n e s i s 5531
Signal transduction 21 14 12 7
Stress response 11 11 8 3
T r a n s p o r t 5332
Table 4: Detection of differentially expressed genes by IVT Protocol for different functional gene categories
Functional Category 
P(FC < 1/2 ∪ FC > 2)
Number of Genes 
Detected by IVT with 
>.99
Number of Genes also Detected by dIVT with
>.90 >.95 >.99
A p o p t o s i s  r e g u l a t o r 1100
C e l l - c e l l  s i g n a l i n g 9774
Cell cycle 6320
C e l l  d e a t h 3211
Cell motility 5440
Cell proliferation 13 10 8 5
D e f e n s e  a n d  I m m u n i t y 5552
Extracelullar 19 14 11 5
H o m e o s t a s i s 0000
Nucleic acid binding 16 7 6 3
P a t h o g e n e s i s 6211
Signal transduction 27 18 13 7
Stress response 15 13 12 3
T r a n s p o r t 1 1 852BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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105  cells/insert; Transwell-clear membranes, Costar,
Cambridge, MA) and maintained in serum free BEGM
media (Clonetics, San Diego, CA), containing insulin (5
µg/ml), transferrin (10 µg/ml), epinephrine (0.5 µg/ml),
triiodothyronine (6.5 ng/ml), epidermal growth factor
(0.5 ng/ml), bovine pituitary extract (1% vol/vol), gen-
tamicin (50 µg/ml), amphotericin B (50 ng/ml), and
retinoic acid (5 × 10-8 M), until differentiated mucociliary
bronchial epithelial cells were visible under a microscope.
NCI-H292 cells were seeded at a density of 106 cells per
well in 6-well, flat-bottom, tissue culture plates (Corning,
Corning, NY). Cultures were maintained in RPMI 1640
medium (Invitrogen Corporation, Carlsbad, CA) supple-
mented with 10% fetal bovine serum (Invitrogen Corpo-
ration, Carlsbad, CA), penicillin (100 U/ml), and
streptomycin (100 g/ml). For RNA extraction, cells were
washed twice in 1 x PBS. The suspension was homoge-
nized by 5–10 passages through a 20-gauge needle (0.9
mm diameter), passed through an RNeasy mini-column
(RNeasy kit; Qiagen, Valencia, CA), and RNA was eluted
in RNase-free water. RNA quantitation was performed by
measuring absorbance of the RNA sample solutions at
260 nm. The RNA integrity was determined by formalde-
hyde-agarose gel electrophoresis.
Target Preparation
For the standard protocol (IVT), 5 µg of total RNA was
reverse-transcribed in a 20 µl reaction with 200 U Super-
Script II (Invitrogen Corporation, Carlsbad, CA) and 100
pmol of T7-(dT)24  primer (5'-GGCCAGTGAATTG-
TAATACGACTCACTATAGGGAGGC GG-(dT)24-3') in 1X
first-strand buffer (Invitrogen Corporation, Carlsbad, CA)
at 42°C for 1 h. The second-strand synthesis was per-
formed at 16°C for 2 h, in the presence of E. coli enzymes,
DNA Polymerase I (40 U), DNA ligase (10 U), RNase H (2
U) and 1X second-strand buffer (Invitrogen Corporation,
Carlsbad, CA). The double-stranded cDNA was blunt-
ended using 20 U of T4 DNA polymerase, purified by phe-
nol/chloroform extraction and transcribed in the presence
of biotin labeled-ribonucleotides, using the BioArray
HighYield RNA transcript labeling kit (Enzo Laboratories,
Farmingdale, NY) as described by the manufacturer. The
biotin-labeled cRNA was purified using RNeasy mini-col-
umn (RNeasy kit; Qiagen, Valencia, CA) and fragmented
at 94°C for 35 min in 1X fragmentation buffer (40
mMTris-acetate, pH 8.0, 100 mM KOAc, 30 mM MgOAc).
For the dIVT protocol, the first and second cDNA strands
were synthesized as described above. The first transcrip-
tion was performed in the absence of biotin-labeled ribo-
nucleotides, resulting in unlabeled cRNA, which was then
used as starting material for the second cycle. In the sec-
ond cycle, the first and second cDNA strands were synthe-
sized as described above. The second transcription was
performed in the presence of biotin-labeled-ribonucle-
otides, resulting in labeled cRNA. The cRNA was frag-
mented and checked by gel electrophoresis, as reported
earlier [7]. A representative picture of such a gel is shown
in figure 1. The intact cRNA samples that appear as a
smear on gels are reduced to 50–100 bp fragments after
treatment.
Hybridization, Staining and Imaging
The Affymetrix GeneChip system was used for hybridiza-
tion, staining and imaging of the probe arrays. Hybridiza-
tion cocktails of 300 µl each containing 15 µg of cRNA
and exogenous hybridization controls were prepared as
described previously [7] and hybridized to U95Av2 Gene-
Chips (Affymetrix, Santa Clara, CA) overnight at 42°C.
Hybridized fragments were detected using streptavidin-
linked to phycoerythrin (Molecular Probes, Eugene, OR;
[7]). GeneChips were scanned and imaged using Affyme-
trix Microarray Analysis Suite (MAS), version 5.0 [10]. The
MAS expression data report was generated for each sample
and used to judge the quality of sample preparation and
Table 5: Comparison of microarray and QRT-PCR estimates of FC for selected genes
Gene Est. Array FC* IVT Est. Array FC dIVT QRT-PCR Lower 
90%
QRT-PCR Est. FC QRT-PCR Upper 
90%
TNF 1/19.53 1/153.58 1/99.52 1/11.31 1/1.29
K6A 1/16.2 1/17.95 1/344.62 1/56.69 1/9.33
SFP 47.7 54 1/2.02 1/1.05 1.82
IGFB 10.82 8.8 1.42 2.51 4.41
LOH 1/21.21 1/5.66 1/11.28 1/3.61 1/1.15
AXL 36.82 13.02 1/1.21 2.51 7.57
DMP 1/18.94 1/29.04 1/55.24 1/28.34 1/14.54
GR 1/4.67 1/20.49 1/50.05 1/10.37 1/2.15
EGFR 4.58 6.27 1/37.44 1/10.85 1/3.15
NFKB 2.38 5.66 10.08 12.98 16.71
*Est. Array FC in bold met criteria P(FC < 1/2 ∪ FC > 2) >.99.BMC Genomics 2004, 5 http://www.biomedcentral.com/1471-2164/5/2
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hybridization. The report includes information about
noise, background and percentage of probe sets called
present based on arbitrary threshold values [10]. Informa-
tion about performance of exogenously added prokaryo-
tic hybridization control genes such as BioB, BioC and
BioD [7] of the E. coli biotin synthesis pathway and the
ratio of intensities of 3' probes to 5' probes for housekeep-
ing genes such as GAPDH and β-actin are also included in
the report.
Microarray Data Analysis
MAS, version 5.0, [10] was used for data acquisition,
quantification, and normalization. This software is
designed to take as input either the raw binary file con-
taining the TIFF image pixel level information or a .CEL
file, a smaller sized file summarizing the raw file. The soft-
ware output includes summary statistics of probe set
intensity such as signal and p-values for detection (detec-
tion p-values) testing whether or not signal was signifi-
cantly greater than 0. Quality of the automated grid
alignment was assessed using a MATLAB (The Math-
Works, Natick, MA) script [11]. These were developed to
perform high-throughput quality control with Affymetrix
GeneChips. Overall array quality was assessed using the
MAS 5.0 detection p-values along with the outlier detec-
tion implemented in dChip [12]. Normalized data was
exported from MAS 5.0 to S-Plus (Insightful Corp., Seattle
WA), where the gene expression values were transformed
by computing the logarithm (base two). We identified dif-
ferentially expressed genes by constructing a linear model
that accounted for known factors in the experimental
design and applying Bayesian methods [13] to compute
the posterior probability of a desired fold change (FC).
Quantitative Real Time PCR (QRT-PCR)
Differentially expressed genes identified by microarray
data analysis were validated by QRT-PCR. Four micro-
grams of template RNA were used in 210 µl of RT reaction
mix according to the manufacturer's instructions using the
GeneAmp RNA PCR Core Kit (Applied Biosystems, Foster
City, CA, USA). The reaction was performed at 42°C for
30 min followed by denaturation of enzymes at 95°C for
5 min. Each QRT-PCR was performed in quadruplicate in
25 µl volume in iCycler (Bio-Rad, Hercules, CA) using
SYBR Green PCR Core Reagents (Applied Biosystems, Fos-
ter City, CA). Each PCR reaction used 0.2 mM of each
gene-specific primer (Invitrogen Corporation, Carlsbad,
CA), 3 mM MgCl2, and 3 µl of RT mix. GADPH was used
as a reference. Delete sentence The thermo-cycling profile
used was 55°C for 3 min, 95°C for 8 min, and 40 cycles
of denaturation at 95°C for 20 sec and elongation at 60°C
for 60 sec.
QRT-PCR Data Analysis
The QRT-PCR data were analyzed using the comparative
CT method [14]. Briefly, the difference in cycle times,
∆CT, was determined as the difference between the tested
gene and the reference housekeeping gene, GAPDH. We
then obtained ∆∆CT by finding the difference between
treatments. The fold change was calculated as
. To determine confidence intervals, we used
replicate measurements and experiments to model the
variability in ∆∆CT with a normal distribution. We then
converted the intervals to the fold-change scale.
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